ABCB1 Modulation Does Not Circumvent Drug Extrusion From Primitive Leukemic Progenitor Cells and May Preferentially Target Residual Normal Cells in Acute Myelogenous Leukemia
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-1945
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2006
Authors
Publisher
American Association for Cancer Research (AACR)